Natixis’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-10,900
Closed -$578K 1112
2024
Q2
$578K Buy
+10,900
New +$578K ﹤0.01% 574